Pays: Australie
Langue: anglais
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
TRIMETHOPRIM; SULFADIAZINE
JUROX PTY LIMITED
PARENTERAL LIQUID/SOLUTION/SUSPENSION
TRIMETHOPRIM PYRIMIDINE Active 80.0 mg/ml; SULFADIAZINE SULFANYL Active 400.0 mg/ml
100 mL; 50 mL
VM - Veterinary Medicine
ANTIBIOTIC & RELATED
Poison schedule: 4; Withholding period: MEAT (CATTLE, SHEEP, PIG, HORSE): DO NO T USE less than 28 days before slaughter for human consumption MILK (CATTLE): Milk collected from cows within 72 hour s following treatment MUST NOT BE USED f or human consumption or processing. This milk should not be fed to bobby calves . MILK (SHEEP): DO NOT USE in female sheep which are producing or may in the future produce milk or milk products for human consumption. EXPORT SLAUGHTER INTERVAL (ESI): An ESI has not been esta blished for this product. Note - observ ing the meat withholding period may not be sufficient to mitigate potential risk s to export trade. Trade advice should b e sought from Jurox Pty Limited on 1800 023 312 before using the product.; Host/pest details: CATTLE: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; HORSE: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; PIGS: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]; SHEEP EWE - DRY: [BACTERIAL INFECTION, INFECTIONS OF THE ALIMENTARY TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE UROGENITAL TRACT]
Registered
2023-07-01
JUROX TMPS ANTIBACTERIAL SUSPENSION FOR INJECTION 89892/126303 Product Name: APVMA Approval No: Label Name: JUROX TMPS ANTIBACTERIAL SUSPENSION FOR INJECTION Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 400 mg/mL Sulfadiazine 80 mg/mL Trimethoprim Claims: Jurox TMPS Antibacterial Suspension for Injection contains 80 mg/mL trimethoprim, a synthetic antibacterial developed in the Wellcome Research Laboratories, and 400 mg/mL sulfadiazine. Jurox TMPS Antibacterial Suspension for Injection is effective against most Gram-positive and Gram-negative bacteria. The two components of Jurox TMPS Antibacterial Suspension for Injection produce a sequential double blockade of bacterial metabolism giving a level of activity many times greater than that obtained from either drug alone. Jurox TMPS Antibacterial Suspension for Injection may be used in the treatment of a wide range of diseases and conditions of bacterial origin in cattle, sheep, pigs and horses. Jurox TMPS Antibacterial Suspension for Injection is indicated for the systemic treatment of: Respiratory infections of bacterial origin including pneumonia, bronchitis and secondary bacterial infections following virus pneumonia. Urogenital tract infections including cystitis, vaginitis, urethritis, nephritis and metritis. Alimentary tract infections including Escherichia coli infections and salmonellosis. Other infections, as such foul-in-the-foot, severe mastitis, bacterial agalactia of sows, post-operative and post-parturient uses, wound infections and septicaemias. Jurox TMPS Antibacterial Suspension for Injection is active in vitro against Gram-positive and Gram-negative organisms including Actinomyces spp., Bacillus anthracis, Bordetella spp., Brucella spp., Clostridium spp., Corynebacterium spp., E. coli, Haemophilus spp., Klebsiella spp., Shigella spp., Staphylococci, Streptococci, Diplococci, Enterococci and Campylobacter spp. Note Erysipelothrix, Leptospira and Pseudomonas organisms ar Lire le document complet